These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21945484)

  • 1. Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction?
    Skinbjerg M; Sibley DR; Javitch JA; Abi-Dargham A
    Biochem Pharmacol; 2012 Jan; 83(2):193-8. PubMed ID: 21945484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine.
    Kodaka F; Ito H; Takano H; Takahashi H; Arakawa R; Miyoshi M; Okumura M; Otsuka T; Nakayama K; Halldin C; Farde L; Suhara T
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):83-9. PubMed ID: 20860881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current state of agonist radioligands for imaging of brain dopamine D2/D3 receptors in vivo with positron emission tomography.
    Finnema SJ; Bang-Andersen B; Wikström HV; Halldin C
    Curr Top Med Chem; 2010; 10(15):1477-98. PubMed ID: 20583987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
    Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
    Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of the proportion of D2 receptors configured in state of high affinity for agonists in vivo: a positron emission tomography study using [11C]N-propyl-norapomorphine and [11C]raclopride in baboons.
    Narendran R; Hwang DR; Slifstein M; Hwang Y; Huang Y; Ekelund J; Guillin O; Scher E; Martinez D; Laruelle M
    J Pharmacol Exp Ther; 2005 Oct; 315(1):80-90. PubMed ID: 16014571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.
    van Wieringen JP; Booij J; Shalgunov V; Elsinga P; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Feb; 386(2):135-54. PubMed ID: 23224422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupancy of dopamine D2/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPA.
    Seneca N; Zoghbi SS; Skinbjerg M; Liow JS; Hong J; Sibley DR; Pike VW; Halldin C; Innis RB
    Synapse; 2008 Oct; 62(10):756-63. PubMed ID: 18651641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.
    Graff-Guerrero A; Willeit M; Ginovart N; Mamo D; Mizrahi R; Rusjan P; Vitcu I; Seeman P; Wilson AA; Kapur S
    Hum Brain Mapp; 2008 Apr; 29(4):400-10. PubMed ID: 17497628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
    J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.
    McCormick PN; Kapur S; Reckless G; Wilson AA
    Synapse; 2009 Nov; 63(11):998-1009. PubMed ID: 19598174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine beta-hydroxylase-deficient mice have normal densities of D(2) dopamine receptors in the high-affinity state based on in vivo PET imaging and in vitro radioligand binding.
    Skinbjerg M; Seneca N; Liow JS; Hong J; Weinshenker D; Pike VW; Halldin C; Sibley DR; Innis RB
    Synapse; 2010 Sep; 64(9):699-703. PubMed ID: 20336622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron-labeled dopamine agonists for probing the high affinity states of dopamine subtype 2 receptors.
    Hwang DR; Narendran R; Laruelle M
    Bioconjug Chem; 2005; 16(1):27-31. PubMed ID: 15656572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D(2/3) receptor occupancy of apomorphine in the nonhuman primate brain--a comparative PET study with [11C]raclopride and [11C]MNPA.
    Finnema SJ; Halldin C; Bang-Andersen B; Gulyás B; Bundgaard C; Wikström HV; Farde L
    Synapse; 2009 May; 63(5):378-89. PubMed ID: 19173265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography study.
    Narendran R; Martinez D; Mason NS; Lopresti BJ; Himes ML; Chen CM; May MA; Price JC; Mathis CA; Frankle WG
    Synapse; 2011 Dec; 65(12):1344-9. PubMed ID: 21780185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.
    Wilcox RE; Huang WH; Brusniak MY; Wilcox DM; Pearlman RS; Teeter MM; DuRand CJ; Wiens BL; Neve KA
    J Med Chem; 2000 Aug; 43(16):3005-19. PubMed ID: 10956209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.
    Seneca N; Finnema SJ; Farde L; Gulyás B; Wikström HV; Halldin C; Innis RB
    Synapse; 2006 Apr; 59(5):260-9. PubMed ID: 16416444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-dependent internalization of D2 receptors: Imaging quantification by confocal microscopy.
    Goggi JL; Sardini A; Egerton A; Strange PG; Grasby PM
    Synapse; 2007 Apr; 61(4):231-41. PubMed ID: 17230553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization.
    Wang M; Pei L; Fletcher PJ; Kapur S; Seeman P; Liu F
    Mol Brain; 2010 Sep; 3():25. PubMed ID: 20813060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
    Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
    Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.